lung cancer | |||||
新闻 | |||||
Daiichi Sankyo's Datroway gets Japanese regulatory nod for first TROP-2 directed therapy ... In Japan, breast cancer is the most common cancer in women.1 ... The programme includes seven phase 3 trials in lung cancer and five ...
| |||||
Discovery of an Efficacious RET PROTAC Degrader with Enhanced Antiproliferative Activity ... ... cancers, including thyroid cancer and lung adenocarcinoma. (5) For example, approximately 55% of patients with sporadic medullary thyroid ...
| |||||
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment